Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS)
CNY 40.45
(0.12%)
CNY 40.45
(0.12%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 573.86 Million CNY | -29.29% |
| 2022 | 442.17 Million CNY | 21.06% |
| 2021 | 365.23 Million CNY | 127.12% |
| 2020 | 160.81 Million CNY | 53.1% |
| 2019 | 105.03 Million CNY | 11.86% |
| 2018 | 93.89 Million CNY | -6.42% |
| 2017 | 100.33 Million CNY | 66.34% |
| 2016 | 60.31 Million CNY | -29.47% |
| 2015 | 85.52 Million CNY | -32.87% |
| 2014 | 127.4 Million CNY | 18.01% |
| 2013 | 107.95 Million CNY | 15.28% |
| 2012 | 93.65 Million CNY | 0.25% |
| 2011 | 93.41 Million CNY | 18.62% |
| 2010 | 78.74 Million CNY | 49.01% |
| 2009 | 52.84 Million CNY | 190.72% |
| 2008 | 18.17 Million CNY | -9.97% |
| 2007 | 20.19 Million CNY | -8.1% |
| 2006 | 21.97 Million CNY | -29.02% |
| 2005 | 30.95 Million CNY | -33.92% |
| 2004 | 46.84 Million CNY | 1.71% |
| 2003 | 46.05 Million CNY | -2.0% |
| 2002 | 46.99 Million CNY | 12.52% |
| 2001 | 41.76 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 56.07 Million CNY | 49.04% |
| 2024 Q3 | 89.1 Million CNY | 58.9% |
| 2024 Q1 | 37.62 Million CNY | -29.22% |
| 2023 Q2 | 172.52 Million CNY | 55.69% |
| 2023 Q1 | 110.8 Million CNY | -16.37% |
| 2023 Q4 | 53.15 Million CNY | -69.81% |
| 2023 Q3 | 176.05 Million CNY | 2.05% |
| 2023 FY | 312.67 Million CNY | -29.29% |
| 2022 Q4 | 132.5 Million CNY | -4.45% |
| 2022 Q3 | 138.67 Million CNY | 13.39% |
| 2022 Q2 | 122.3 Million CNY | 24.76% |
| 2022 Q1 | 98.02 Million CNY | 23.01% |
| 2022 FY | 442.17 Million CNY | 21.06% |
| 2021 FY | 365.23 Million CNY | 127.12% |
| 2021 Q1 | 78.23 Million CNY | 243.73% |
| 2021 Q3 | 98.42 Million CNY | -9.61% |
| 2021 Q4 | 79.69 Million CNY | -19.03% |
| 2021 Q2 | 108.88 Million CNY | 39.19% |
| 2020 Q1 | 22.89 Million CNY | -13.42% |
| 2020 Q2 | 39.35 Million CNY | 71.9% |
| 2020 Q3 | 75.8 Million CNY | 92.61% |
| 2020 Q4 | 22.75 Million CNY | -69.98% |
| 2020 FY | 160.81 Million CNY | 53.1% |
| 2019 Q1 | 30.79 Million CNY | 116.11% |
| 2019 Q3 | 18.49 Million CNY | -36.9% |
| 2019 Q2 | 29.3 Million CNY | -4.86% |
| 2019 FY | 105.03 Million CNY | 11.86% |
| 2019 Q4 | 26.44 Million CNY | 43.01% |
| 2018 Q4 | 14.25 Million CNY | -14.36% |
| 2018 Q2 | 32.9 Million CNY | 9.3% |
| 2018 Q1 | 30.1 Million CNY | 18.56% |
| 2018 FY | 93.89 Million CNY | -6.42% |
| 2018 Q3 | 16.64 Million CNY | -49.42% |
| 2017 Q2 | 34.2 Million CNY | 69.01% |
| 2017 Q4 | 25.38 Million CNY | 23.85% |
| 2017 Q1 | 20.24 Million CNY | 1092.13% |
| 2017 Q3 | 20.5 Million CNY | -40.07% |
| 2017 FY | 100.33 Million CNY | 66.34% |
| 2016 Q3 | 15.05 Million CNY | -25.62% |
| 2016 Q4 | -2.04 Million CNY | -113.55% |
| 2016 FY | 60.31 Million CNY | -29.47% |
| 2016 Q2 | 20.23 Million CNY | -25.26% |
| 2016 Q1 | 27.07 Million CNY | 216.12% |
| 2015 Q2 | 23.57 Million CNY | -14.42% |
| 2015 Q4 | 8.56 Million CNY | -66.86% |
| 2015 Q3 | 25.84 Million CNY | 9.62% |
| 2015 Q1 | 27.54 Million CNY | 235.85% |
| 2015 FY | 85.52 Million CNY | -32.87% |
| 2014 Q4 | 8.2 Million CNY | -82.81% |
| 2014 Q3 | 47.71 Million CNY | 17.56% |
| 2014 Q1 | 30.89 Million CNY | 122.95% |
| 2014 Q2 | 40.58 Million CNY | 31.36% |
| 2014 FY | 127.4 Million CNY | 18.01% |
| 2013 Q4 | 13.85 Million CNY | -62.48% |
| 2013 FY | 107.95 Million CNY | 15.28% |
| 2013 Q3 | 36.94 Million CNY | 31.48% |
| 2013 Q2 | 28.09 Million CNY | -3.32% |
| 2013 Q1 | 29.06 Million CNY | 76.42% |
| 2012 FY | 93.65 Million CNY | 0.25% |
| 2012 Q4 | 16.47 Million CNY | -42.5% |
| 2012 Q2 | 24.13 Million CNY | -1.03% |
| 2012 Q3 | 28.64 Million CNY | 18.68% |
| 2012 Q1 | 24.39 Million CNY | 23.12% |
| 2011 Q2 | 26.42 Million CNY | 52.0% |
| 2011 Q4 | 19.81 Million CNY | -33.48% |
| 2011 Q3 | 29.78 Million CNY | 12.69% |
| 2011 FY | 93.41 Million CNY | 18.62% |
| 2011 Q1 | 17.38 Million CNY | 4.74% |
| 2010 Q4 | 16.6 Million CNY | -36.01% |
| 2010 Q1 | 19.01 Million CNY | 60.22% |
| 2010 Q3 | 25.94 Million CNY | 50.91% |
| 2010 FY | 78.74 Million CNY | 49.01% |
| 2010 Q2 | 17.18 Million CNY | -9.6% |
| 2009 Q4 | 11.86 Million CNY | -10.75% |
| 2009 Q2 | 14.69 Million CNY | 13.14% |
| 2009 Q1 | 12.98 Million CNY | 1890.37% |
| 2009 FY | 52.84 Million CNY | 190.72% |
| 2009 Q3 | 13.29 Million CNY | -9.5% |
| 2008 Q3 | 5.25 Million CNY | -33.34% |
| 2008 Q4 | -725.35 Thousand CNY | -113.8% |
| 2008 FY | 18.17 Million CNY | -9.97% |
| 2008 Q2 | 7.88 Million CNY | 36.96% |
| 2008 Q1 | 5.75 Million CNY | 75.0% |
| 2007 Q2 | 7.23 Million CNY | 417.44% |
| 2007 Q4 | 3.29 Million CNY | -60.18% |
| 2007 Q3 | 8.26 Million CNY | 14.15% |
| 2007 Q1 | 1.39 Million CNY | 133.33% |
| 2007 FY | 20.19 Million CNY | -8.1% |
| 2006 Q2 | 4.9 Million CNY | -31.25% |
| 2006 Q3 | 14.12 Million CNY | 187.91% |
| 2006 FY | 21.97 Million CNY | -29.02% |
| 2006 Q4 | -4.19 Million CNY | -129.71% |
| 2006 Q1 | 7.13 Million CNY | -22.98% |
| 2005 Q1 | 5.81 Million CNY | -72.94% |
| 2005 FY | 30.95 Million CNY | -33.92% |
| 2005 Q4 | 9.26 Million CNY | -33.38% |
| 2005 Q3 | 13.9 Million CNY | 584.26% |
| 2005 Q2 | 2.03 Million CNY | -65.05% |
| 2004 FY | 46.84 Million CNY | 1.71% |
| 2004 Q4 | 21.49 Million CNY | 189.02% |
| 2004 Q3 | 7.43 Million CNY | -1.28% |
| 2004 Q2 | 7.53 Million CNY | -26.57% |
| 2004 Q1 | 10.25 Million CNY | -52.97% |
| 2003 Q4 | 21.81 Million CNY | 178.18% |
| 2003 Q2 | 16.4 Million CNY | 957.33% |
| 2003 FY | 46.05 Million CNY | -2.0% |
| 2003 Q1 | 1.55 Million CNY | 0.0% |
| 2003 Q3 | 7.84 Million CNY | -52.2% |
| 2002 FY | 46.99 Million CNY | 12.52% |
| 2001 FY | 41.76 Million CNY | 0.0% |